Please refer to Summary of Product Characteristics before prescribing. Further information about this product can be requested from the Marketing Authorisation Holder or may be found in the Summary of Product Characteristics.
Contains: Tropicamide Ph. Eur. 0.5 % and 1% w/v.
Main Indications, Dosage and Administration: As a topical mydriatic and cycloplegic. Adults (including the elderly): 1 drop followed by a second drop after an interval of 5 minutes. A further 1 drop may be instilled after 30 minutes, if required. Children: At the discretion of the physician.
Contraindications, Precautions and Warnings: Do not use in patients with a known hypersensitivity to tropicamide. Tropicamide is contraindicated in narrow angle glaucoma and in eyes where the filtration angle is narrow, as an acute attack of angle closure glaucoma may be precipitated. Use with caution in an inflamed eye, as hyperaemia greatly increases the rate of systemic absorption through the conjunctiva. Care should be exercised in small children. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of drops via the naso-lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.) Tropicamide may cause increased intraocular pressure. The possibility of undiagnosed glaucoma should be considered in some patients, such as elderly patients. Determine the intraocular pressure and an estimation of the depth of the angle of the anterior chamber prior to initiation of therapy. Patient warning: Patients who receive a mydriatic may suffer from photophobia and this may impair their ability to drive under certain circumstances.
Pregnancy and Lactation: There is no evidence as to the drug's safety in human pregnancy, nor is there evidence from animal work that it is free from hazard. This product should only be used in pregnancy if considered essential by the physician.
Undesirable Effects: Transient stinging, dry mouth and blurred vision may occur following the use of this product.
Legal Category: POM
Minims Tropicamide 0.5%: UK PL No: PL 03468/0084 Basic NHS Price: £12.33
Minims Tropicamide 1.0%: UK PL No: PL 03468/0085 Basic NHS Price: £12.47
Marketing Authorisation Holder: Bausch & Lomb UK Limited, Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, UK, KT2 6TN
Date of Revision: March 2023
Exemption Level: 1
Evocative Code: TRO 0.5, TRO 1.0
PIP Code: 015-2702, 015-2710
The website you are about to visit is not affiliated with Bausch + Lomb Incorporated. Bausch + Lomb is not responsible for the content, format, maintenance, or policies of the website you are about to enter and does not monitor non-affiliated websites for accuracy. Links to non-affiliated websites are provided as a convenience; they do not constitute an endorsement or support of any programs, products, or services associated with the website.